Skip to content
Disclosery

Clayton, Dubilier & Rice, LLC

Follow

13F filer, CIK 1538642, NEW YORK, NY

Clayton, Dubilier & Rice, LLC reported $594,962,107 across 2 holdings for the quarter ended 2025-12-31, in a 13F-HR filed 2026-02-09.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001104659-26-011833

Period
2025-12-31
Reported value
$595M
Holdings
2
Top 10 weight
100%
New
0
Sold out
0

Largest buys vs the previous quarter

SecurityShares changeApprox. value
REZIadded+1,689,758$59.3M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

None.

Holdings, Q4 2025

Share positions as resolved from 13F-HR 0001104659-26-011833, largest first. % of portfolio is the value over $594,962,107, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
REZIRESIDEO TECHNOLOGIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 5,770,151 shares; 2025Q3: 13,286,384 shares; 2025Q4: 14,976,142 shares 14,976,142$526M88.4%+1,689,758Timeline
AGLAGILON HEALTH INC COM (DE)Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 100,000,000 shares; 2024Q4: 100,000,000 shares; 2025Q1: 100,000,000 shares; 2025Q2: 100,000,000 shares; 2025Q3: 100,000,000 shares; 2025Q4: 100,000,000 shares 100,000,000$69M11.6%0Timeline

How Q4 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001104659-26-011833 base2026-02-09acceptance time not in the bulk data set